Home / Publication / Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

刊物

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: 双氯芬酸钠局部用凝胶案例，1％

Author(s): Eleftheria Tsakalozou, Andrew Babiskin, LiangZhao

Year: 2020 年 12 月 29 日

肿瘤领域模型引导的药物开发（MIDD）精要

博客

Non-Animal Navigator™: 专家策略与 AI 生物模拟减少、优化或替代动物实验

事实资料表

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions

网络研讨会

Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy

案例研究

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: 双氯芬酸钠局部用凝胶案例，1％

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: 双氯芬酸钠局部用凝胶案例，1％

肿瘤领域模型引导的药物开发（MIDD）精要

Non-Animal Navigator™: 专家策略与 AI 生物模拟减少、优化或替代动物实验

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions

Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy

订阅时事通讯

快捷链接

解决方案

联系我们